Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 6, 2025, it ...

We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at ...

Craig-Hallum analyst William Bonello maintained a Buy rating on Guardant Health (GH – Research Report) today. The company’s shares closed ...

Guardant Health (GH) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock ...

BTIG raised the price target for Guardant Health (NASDAQ:GH) to $55.00, up from the previous target of $50.00, while maintaining a Buy rating on the stock. The adjustment came as Guardant Health ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results ...

Learn more about whether Guardant Health, Inc. or Premier, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

SG Americas Securities LLC decreased its position in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 43.1% during the 4th ...

Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have been given an average rating of “Buy” by the fifteen analysts that are covering the company, MarketBeat.com reports.